St. John Providence Health System Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2004
NCT00150657
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

St. John Providence Health System, Novi, MI

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Kidney Injury (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Cellulitis (Phase 4)

Communicable Diseases (Phase 4)

Infections (Phase 4)

Lung Neoplasms (Phase 2)

Skin Diseases (Phase 4)

Skin Diseases, Infectious (Phase 4)

Staphylococcal Skin Infections (Phase 4)

Wounds and Injuries (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 6